Skip to content

Effect of Heatwave Over Glycemic Control in Patients With T1D

Effect of the Greatest Spanish Heatwave Over Glycemic Control in Adult Patients With Type 1 Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05646017
Enrollment
2701
Registered
2022-12-12
Start date
2022-12-15
Completion date
2023-01-31
Last updated
2023-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

Diabetes, Type 1 diabetes

Brief summary

Observational study about effect of the greatest Spanish heatwave over glycemic contro in adult patients with type 1 Diabetes mellitus.

Detailed description

Cross-sectional retrospective analysis of all patients with T1D in Castilla-La Mancha (south-central Spanish region) using intermittently scanned continuous glucose monitoring (isCGM). Glycometric data obtained through deidentified downloads from isCGM´s webpage. Primary outcome was time in range (TIR) 3.0-10 mmol/L (70-180 mg/d) change after the heatwave. Data analysis is conducted using SPSS (Chicago, IL) statistics software. Results are presented as mean ± SD values or percentages. A paired Student's t-test or a Wilcoxon signed-rank test were used for the analysis of differences. Comparisons between proportions were analyzed using a chi-squared test. A P value \< 0.05 was considered statistically significant. The protocol was approved by the reference Castilla-La Mancha Public Health Institute Ethic Committee.

Interventions

Use of Intermittenly scanned continuous glucose monitoring (FreeStyle Libre)

Sponsors

Castilla-La Mancha Health Service
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Type 1 diabetes * Older than 18 years old * Using intermittently scanned continuous glucose monitoring (isCGM) * Paired active isCGM data from the heatwave period and two consecutive weeks

Exclusion criteria

* Younger than 18 years old * Not using intermittently scanned continuous glucose monitoring * Not having active paired isCGM data from the analyzed periods

Design outcomes

Primary

MeasureTime frameDescription
Change in Time in range14 daysChange in Time in range (TIR) 3.0-10 mmol/L (70-180 mg/d) of interstitial glucose from the heatwave period to 14 days after its end

Secondary

MeasureTime frameDescription
Change in Adherence to Flash 114 daysChange in Time of use of intermittently scanned continuous glucose monitoring (% possible time of use) from the heatwave period to 14 days after its end
Change in Adherence to Flash 214 daysChange in Number of intermittently scanned continuous glucose monitoring daily scanning (number of scans/day) from the heatwave period to 14 days after its end
Change in Time below range 1 (TBR1)14 daysChange in Time bellow range \<3.9 mmol/L (\<70 mg/dL) of the interstitial glucose from the heatwave period to 14 days after its endfrom the heatwave period to 14 days after its end
Change in Time below range 2 (TBR2)14 daysChange in Time bellow range \<3 mmol/L (\<54 mg/dL) of the interstitial glucose from the heatwave period to 14 days after its end
Change in Time above range 1 (TAR1)14 daysChange in Time above range \>10 mmol/L(\>180 mg/dL) of the interstitial glucose from the heatwave period to 14 days after its end
Change in Coefficient of variation percentage (CV)14 daysChange in Coefficient of variation percentage of interstitial glucose from the heatwave period to 14 days after its end
Change in Glucose management index14 daysChange in Glucose management index of interstitial glucose from the heatwave period to 14 days after its end
Change in Time in hypoglycemia14 daysChange in Daily time in hypoglycemia (\<3.9 mmol/L, \<70 mg/dL) of interstitical glucose from the heatwave period to 14 days after its end
Change in Hypoglycemia frequency14 daysChange in Number of daily hypoglycemic events (\<3.9 mmol/L, \<70 mg/dL) of interstitical glucose from the heatwave period to 14 days after its end
Change in Time above range 2 (TAR2)14 daysChange in Time above range \>13.9 mmol/L (\>250 mg/dL) of the interstitial glucose from the heatwave period to 14 days after its end

Other

MeasureTime frameDescription
Change in Percentage of patients attaining the the International Consensus on Time in Range (ICTR) goals14 daysChange in Percentage of patients (from total) attaining TIR\>70%, TBR1\<4%, TBR2\<1%, TAR1\<25%, TAR2\<5% and CV \<36% from the heatwave period to 14 days after its end

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026